These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 25385007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles.
    Tu B, Zhang H, Chen L, Yang R, Liu P, Li R, Qiao J.
    J Ovarian Res; 2024 Jul 03; 17(1):137. PubMed ID: 38961417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X, Hong Q, Sun L, Chen Q, Fu Y, Ai A, Lyu Q, Kuang Y.
    Fertil Steril; 2016 Nov 03; 106(6):1356-1362. PubMed ID: 27490046
    [Abstract] [Full Text] [Related]

  • 8. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
    Fabris AM, Cruz M, Legidos V, Iglesias C, Muñoz M, García-Velasco JA.
    Reprod Sci; 2017 Aug 03; 24(8):1221-1225. PubMed ID: 28715965
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study.
    Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, Orvieto R.
    Gynecol Endocrinol; 2019 Jul 03; 35(7):628-630. PubMed ID: 30810400
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
    Yan MH, Cao JX, Hou JW, Jiang WJ, Wang DD, Sun ZG, Song JY.
    Front Endocrinol (Lausanne); 2022 Jul 03; 13():831859. PubMed ID: 35418945
    [Abstract] [Full Text] [Related]

  • 15. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study.
    Haas J, Ophir L, Barzilay E, Machtinger R, Yung Y, Orvieto R, Hourvitz A.
    Fertil Steril; 2016 Sep 01; 106(3):653-659.e1. PubMed ID: 27341989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug 01; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.
    Hum Reprod Update; 2006 Aug 01; 12(2):159-68. PubMed ID: 16254001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.